Keira Kim

Keira Kim is a seasoned Medical Writing professional with extensive experience in the biopharmaceutical industry. Currently serving as Senior Manager of Medical Writing in Medical Affairs at Viridian Therapeutics, Inc., since June 2022, Keira leads the writing and submission of key preclinical and clinical documents and has significantly contributed to the development of the company’s first Clinical Study Report. Prior to this role, Keira was Medical Writing Manager at Greenwich Biosciences, managing medical writing activities for products like Epidiolex and nabiximols, and ensuring the execution of strategic publication plans. Earlier positions include roles at Biomedical Prepublication Services and as a self-employed Medical Writer, focusing on ADHD-related publications. Keira holds a Bachelor of Science in Chemistry with an emphasis in Biochemistry from Humboldt State University and a Master of Science in Drug Development and Product Management from UC San Diego Skaggs School of Pharmacy.